Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 854

1.

Differential effect of fenofibrate and atorvastatin on in vivo kinetics of apolipoproteins B-100 and B-48 in subjects with type 2 diabetes mellitus with marked hypertriglyceridemia.

Hogue JC, Lamarche B, Deshaies Y, Tremblay AJ, Bergeron J, Gagné C, Couture P.

Metabolism. 2008 Feb;57(2):246-54. doi: 10.1016/j.metabol.2007.09.008.

PMID:
18191056
[PubMed - indexed for MEDLINE]
2.

Effects of fenofibrate on apolipoprotein kinetics in patients with coexisting dysbetalipoproteinemia and heterozygous familial hypercholesterolemia.

Tremblay AJ, Lamarche B, Ruel IL, Hogue JC, Deshaies Y, Gagné C, Couture P.

Atherosclerosis. 2006 Sep;188(1):203-12. Epub 2005 Dec 6.

PMID:
16337207
[PubMed - indexed for MEDLINE]
3.

Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.

Watts GF, Barrett PH, Ji J, Serone AP, Chan DC, Croft KD, Loehrer F, Johnson AG.

Diabetes. 2003 Mar;52(3):803-11.

PMID:
12606523
[PubMed - indexed for MEDLINE]
Free Article
4.

Effects of different doses of atorvastatin on human apolipoprotein B-100, B-48, and A-I metabolism.

Lamon-Fava S, Diffenderfer MR, Barrett PH, Buchsbaum A, Matthan NR, Lichtenstein AH, Dolnikowski GG, Horvath K, Asztalos BF, Zago V, Schaefer EJ.

J Lipid Res. 2007 Aug;48(8):1746-53. Epub 2007 May 27.

PMID:
17526934
[PubMed - indexed for MEDLINE]
Free Article
5.

Effects of atorvastatin versus fenofibrate on apoB-100 and apoA-I kinetics in mixed hyperlipidemia.

Bilz S, Wagner S, Schmitz M, Bedynek A, Keller U, Demant T.

J Lipid Res. 2004 Jan;45(1):174-85. Epub 2003 Oct 1.

PMID:
14523053
[PubMed - indexed for MEDLINE]
Free Article
6.

Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: effect of triglyceride reductions with atorvastatin.

Le NA, Innis-Whitehouse W, Li X, Bakker-Arkema R, Black D, Brown WV.

Metabolism. 2000 Feb;49(2):167-77.

PMID:
10690940
[PubMed - indexed for MEDLINE]
7.

Effect of a new HMG-CoA reductase inhibitor, atorvastatin, on lipids, apolipoproteins and lipoprotein particles in patients with elevated serum cholesterol and triglyceride levels.

Alaupovic P, Heinonen T, Shurzinske L, Black DM.

Atherosclerosis. 1997 Aug;133(1):123-33.

PMID:
9258416
[PubMed - indexed for MEDLINE]
8.
9.

Atorvastatin and fenofibrate have comparable effects on VLDL-apolipoprotein C-III kinetics in men with the metabolic syndrome.

Chan DC, Watts GF, Ooi EM, Ji J, Johnson AG, Barrett PH.

Arterioscler Thromb Vasc Biol. 2008 Oct;28(10):1831-7. doi: 10.1161/ATVBAHA.108.170530. Epub 2008 Jun 19.

PMID:
18566295
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Differential effect of atorvastatin and fenofibrate on plasma oxidized low-density lipoprotein, inflammation markers, and cell adhesion molecules in patients with type 2 diabetes mellitus.

Hogue JC, Lamarche B, Tremblay AJ, Bergeron J, Gagné C, Couture P.

Metabolism. 2008 Mar;57(3):380-6. doi: 10.1016/j.metabol.2007.10.014.

PMID:
18249211
[PubMed - indexed for MEDLINE]
11.

Effect of fenofibrate on plasma lipoprotein composition and kinetics in patients with complete hepatic lipase deficiency.

Ruel IL, Lamarche B, Mauger JF, Badellino KO, Cohn JS, Marcil M, Couture P.

Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2600-7. Epub 2005 Oct 13.

PMID:
16224048
[PubMed - indexed for MEDLINE]
Free Article
12.

Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia.

Bakker-Arkema RG, Davidson MH, Goldstein RJ, Davignon J, Isaacsohn JL, Weiss SR, Keilson LM, Brown WV, Miller VT, Shurzinske LJ, Black DM.

JAMA. 1996 Jan 10;275(2):128-33.

PMID:
8531308
[PubMed - indexed for MEDLINE]
13.

Effects of atorvastatin and n-3 fatty acid supplementation on VLDL apolipoprotein C-III kinetics in men with abdominal obesity.

Chan DC, Nguyen MN, Watts GF, Ooi EM, Barrett PH.

Am J Clin Nutr. 2010 Apr;91(4):900-6. doi: 10.3945/ajcn.2009.28422. Epub 2010 Feb 24.

PMID:
20181806
[PubMed - indexed for MEDLINE]
Free Article
14.
15.

Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.

Burnett JR, Wilcox LJ, Telford DE, Kleinstiver SJ, Barrett PH, Newton RS, Huff MW.

Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2589-600.

PMID:
9409231
[PubMed - indexed for MEDLINE]
Free Article
16.

Lovastatin decreases de novo cholesterol synthesis and LDL Apo B-100 production rates in combined-hyperlipidemic males.

Cuchel M, Schaefer EJ, Millar JS, Jones PJ, Dolnikowski GG, Vergani C, Lichtenstein AH.

Arterioscler Thromb Vasc Biol. 1997 Oct;17(10):1910-7.

PMID:
9351353
[PubMed - indexed for MEDLINE]
Free Article
17.

Effect of micronized fenofibrate on plasma lipoprotein levels and hemostatic parameters of hypertriglyceridemic patients with low levels of high-density lipoprotein cholesterol in the fed and fasted state.

Genest J Jr, Nguyen NH, Theroux P, Davignon J, Cohn JS.

J Cardiovasc Pharmacol. 2000 Jan;35(1):164-72.

PMID:
10630748
[PubMed - indexed for MEDLINE]
18.

Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.

Milosavljevic D, Griglio S, Le Naour G, Chapman MJ.

Atherosclerosis. 2001 Mar;155(1):251-60.

PMID:
11223449
[PubMed - indexed for MEDLINE]
19.

Effect of atorvastatin on apolipoprotein B100 containing lipoprotein metabolism in type-2 diabetes.

Ouguerram K, Magot T, Zaïr Y, Marchini JS, Charbonnel B, Laouenan H, Krempf M.

J Pharmacol Exp Ther. 2003 Jul;306(1):332-7. Epub 2003 Apr 8.

PMID:
12684543
[PubMed - indexed for MEDLINE]
Free Article
20.

Atorvastatin treatment lowers fasting remnant-like particle cholesterol and LDL subfraction cholesterol without affecting LDL size in type 2 diabetes mellitus: Relevance for non-HDL cholesterol and apolipoprotein B guideline targets.

Kappelle PJ, Dallinga-Thie GM, Dullaart RP; Diabetes Atorvastatin Lipid Intervention (DALI) study group.

Biochim Biophys Acta. 2010 Jan;1801(1):89-94. doi: 10.1016/j.bbalip.2009.09.021. Epub 2009 Oct 2.

PMID:
19800983
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk